Q2 FY2026 · ended Jun 30, 2026 · Revenue $1.04M, -41.0% YoY · Filed Aug 7, 2026
Bioscience Health Innovations Inc. (BHIC) files with the SEC under industry code 7374, Services-Computer Processing & Data Preparation. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $1.0 million and a net loss of $185,753.
Revenue
$1.04M
-41.0% vs year-ago quarter
Net income
$-185,753
-140.6% vs year-ago quarter
Operating cash flow
$-541,874
-290.1% vs year-ago quarter
Free cash flow
—
EPS
$-0.02
-150.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
11.75M
-73.2% vs year-ago quarter
Net cash
—
Operating margin
-13.7%
TTM
Company profile
- Industry
- Services-Computer Processing & Data Preparation (SIC 7374)
- Listed as
- BHIC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Bluffdale, UT
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1784440
- Former names
- Nowtransit Inc (until Mar 13, 2025)
Other Services-Computer Processing & Data Preparation companies
- Automatic Data Processing Inc ADP
- Workday, Inc. WDAY
- Verisk Analytics, Inc. VRSK
- Toast, Inc. TOST
- Reddit, Inc. RDDT
- Hinge Health, Inc. HNGE
- RingCentral, Inc. RNG
- Pegasystems Inc PEGA
All 110 Services-Computer Processing & Data Preparation companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $1.0M | $750,946 | $1.6M | $1.1M | $1.8M |
| Operating income | -$217,882 | -$229,907 | -$156,669 | -$8,782 | $457,704 |
| Net income | -$185,753 | -$229,907 | -$233,630 | -$8,782 | $457,704 |
| Diluted EPS | -$0.02 | -$0.02 | -$0.02 | $0.00 | $0.04 |
| Operating cash flow | -$541,874 | -$552,107 | -$100,696 | -$340,445 | $285,010 |
| Total assets | $2.1M | $2.3M | $1.7M | $2.1M | $2.1M |
| Total liabilities | $301,209 | $645,749 | $229,851 | $356,140 | $337,632 |
| Stockholders' equity | $1.8M | $1.7M | $1.5M | $1.7M | $1.7M |
| Cash and investments | $712,378 | $1.1M | $661,925 | $1.1M | $1.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2026 | Apr 2, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Oct 27, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Oct 16, 2025 | Sep 10, 2025 |
All 53 Bioscience Health Innovations Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.